Skip to main content

Orchard Therapeutics plc

ORTXDelisted Jan 24, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Orchard Therapeutics plc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ORTX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders50147−2
Shares51.8M22.0K49.4M−2.39M (−4.6%)
Value$30.2M$13.0K$24.7M−$5.55M (−18.4%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Orchard Therapeutics plc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ORTX in Q3 2022
InstitutionSharesValue% of portfolio
Strategic Wealth Advisors Group, LLC516,975$258.0K0.01%
Jane Street Group, LLC45,953$23.0K0.00%
Balyasny Asset Management LLC33,717$17.0K0.00%
Two Sigma Advisers, LP19,500$10.0K0.00%
Allegheny Financial Group LTD16,750$8.00K0.00%
Holderness Investments Co14,730$7.00K0.00%
Two Sigma Securities, LLC13,825$7.00K0.00%
Beaird Harris Wealth Management, LLC120$00.00%

Sold out (10)

Institutions that held Orchard Therapeutics plc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ORTX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Artisan Partners Limited Partnership3,322,737$1.94M
Ra Capital Management, L.P.3,040,885$1.78M
Gsa Capital Partners LLP616,402$360.0K
D. E. Shaw & Co., Inc.226,271$132.0K
New York State Common Retirement Fund115,006$67.0K
State Street Corp110,366$64.0K
SEI Investments Co34,151$20.0K
Lane Generational LLC10,828$6.00K
Concord Wealth Partners1,000$1.00K
Captrust Financial Advisors750$0

Not filed for Q3 2022 yet (1)

Institutions that held Orchard Therapeutics plc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ORTX in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Altium Wealth Management LLC22,000$13.0K